Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2026-01-02 @ 2:04 AM
Study NCT ID:
NCT01798004
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2013-01-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Sponsor:
Children's Oncology Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
ANBL12P1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |